Streetbeat News

Earnings

UTHR

United Therapeutics (NASDAQ:UTHR) is scheduled to release its quarterly earnings report on February 21, 2024. Analysts predict an EPS of $4.19. The company's past earnings performance shows a mix of beats and misses, with the last quarter beating estimates by $0.30, leading to a 1.83% share price increase the following day. Over the last year, UTHR shares have declined by 11.68%, indicating potential investor concern ahead of the earnings announcement. The focus will be on whether UTHR beats the EPS estimate and provides positive guidance for future growth.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 7:01 pm

KRP

Kimbell Royalty Partners (NYSE:KRP) is expected to report an EPS of $0.26 in its upcoming quarterly earnings on February 21, 2024. Analysts and investors will be looking for an earnings beat and positive guidance for future growth. The company's past earnings performance shows mixed results with both misses and beats in previous quarters. Shares of KRP were trading at $15.71 as of February 19, with a 6.1% increase over the last 52 weeks.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 7:01 pm

RCUS

Arcus Biosciences (NYSE:RCUS) is scheduled to release its quarterly earnings report on February 21, 2024, with an expected EPS of $-1.02. The company's past earnings performance shows a mix of beats and misses, with the stock price reacting variably. Shares are currently trading at $16.8, marking a 16.24% decline over the last year. Investors are looking for positive guidance for the next quarter.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 7:01 pm

ACVA

ACV Auctions (NASDAQ:ACVA) is scheduled to release its quarterly earnings report on February 21, 2024, with analysts expecting an EPS of $-0.15. The company's past earnings performance shows a mix of beats and misses, with the stock price reacting variably. Shares are currently trading at $14.29, up 31.4% over the last 52 weeks. Investors are advised to watch for the earnings outcome and particularly the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 7:00 pm

SNPS

Synopsys (NASDAQ:SNPS) has received mixed analyst ratings over the past three months, with 13 analysts offering evaluations. The ratings include 8 bullish and 5 somewhat bullish, with a notable increase in the average 12-month price target to $622.31 from $571.00, indicating a positive outlook. Analysts from firms like Rosenblatt, Needham, B of A Securities, Wells Fargo, Baird, Stifel, and Keybanc have adjusted their ratings and price targets, reflecting changing market dynamics and company performance. Synopsys's financials show strong revenue growth, net margin, and ROA, but a lower ROE compared to industry averages.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 7:00 pm

KO

Coca-Cola has announced that it does not expect international conflicts to materially impact its operational results. For the year 2023, the company recorded other operating charges amounting to approximately $2 billion.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 6:54 pm

C

Citigroup CFO Mark Mason reported positive activity in equities, fixed income, currencies, and commodities, expecting continued loan growth, especially in credit cards. The expense guidance includes $700M-$1B for reorganization and severance, emphasizing that transformation and risk control investments will not be compromised.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 6:48 pm

AMD

DFS

GOOGL

NVDA

WMT

Wall Street experienced a downturn, particularly in technology stocks, with the Nasdaq 100 dropping 1.5%. Nvidia and AMD saw significant declines ahead of Nvidia's earnings report. Alphabet was an exception among major tech stocks, posting a gain. The market's movement reflects a reassessment of stock valuations rather than interest rate concerns. ETFs like SPY, DIA, and QQQ also fell, with XLK underperforming. Walmart's stock rose following strong quarterly results and plans to acquire Vizio, while Discover Financial surged on news of its acquisition by Capital One.

Portfolio Pulse from Piero Cingari

February 20, 2024 | 6:46 pm

AMZN

RIVN

Rivian Automotive Inc (NASDAQ:RIVN) is set to report its Q4 financial results, with analysts expecting a significant revenue increase to $1.262 billion from last year's $663.0 million, and a reduced loss of $1.32 per share. Despite beating earnings estimates in recent quarters, several analysts have downgraded RIVN due to the overall weakness in the EV sector and potential challenges in meeting its 2024 gross margin profitability target. Key items for the upcoming earnings include updates on 2024 production, deliveries, and details on the R2 model debut.

Portfolio Pulse from Chris Katje

February 20, 2024 | 6:41 pm

TEVA

Teva Pharmaceutical Industries (NYSE:TEVA) CEO Richard Francis confirmed the company will not split into two entities, focusing on a unified approach to manage its generics and branded drugs businesses. Despite challenges, Teva remains optimistic, leveraging collaborations with Israeli universities for R&D. The company plans to divest its API business, valued at $1 billion, expecting significant interest. The divestiture is aimed to be completed in the first half of 2025, with TEVA shares currently up 0.88% at $13.14.

Portfolio Pulse from Vandana Singh

February 20, 2024 | 6:24 pm